Revenue: The sum of all revenue fields included for a company's operating activities.
Vir Biotechnology, Inc. (VIR) had Revenue of $3.03M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$3.03M |
$-120.97M |
|
-- |
|
$3.03M |
|
$142.58M |
|
$-139.55M |
|
$18.60M |
|
$-120.95M |
|
$-120.95M |
|
$-120.97M |
|
$-120.97M |
|
$-120.97M |
|
$-120.97M |
|
$-139.55M |
|
$-132.59M |
|
137.47M |
|
137.47M |
|
$-0.88 |
|
$-0.88 |
|
| Balance Sheet Financials | |
$932.21M |
|
$61.68M |
|
$375.52M |
|
$1.31B |
|
$137.29M |
|
-- |
|
$126.62M |
|
$263.91M |
|
$1.04B |
|
$1.02B |
|
$1.04B |
|
138.06M |
|
| Cash Flow Statement Financials | |
$-78.12M |
|
$126.82M |
|
$0.60M |
|
$318.69M |
|
$368.00M |
|
$49.30M |
|
$14.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4602.47% |
|
-4602.47% |
|
-- |
|
-3989.08% |
|
-3989.61% |
|
$-79.46M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-11.59% |
|
-11.87% |
|
-9.25% |
|
-11.59% |
|
$7.56 |
|
$-0.58 |
|
$-0.57 |
|